Development of NIC5-15 in the Treatment of Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

March 31, 2010

Conditions
Alzheimer DiseaseDementia
Interventions
DRUG

NIC5-15

a natural product, found in many foods and plants with mild insulin sensitizing effects

DRUG

Placebo

placebo comparator

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Humanetics Corporation

INDUSTRY

lead

VA Office of Research and Development

FED

NCT00470418 - Development of NIC5-15 in the Treatment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter